Digital Guide: PARP Inhibitors for Ovarian Cancer - Detroit

Dr. Robbie Hanna's guide to using PARP inhibitors as an ovarian cancer treatment

This is Dr. Robbie Hanna’s guide to understanding the use of PARP inhibitors for ovarian cancer.

Dr. Hanna, of the Henry Ford Health System, has collaborated with SurvivorNet for this resource. People in the ovarian cancer community tell us that hearing advice like this, and knowing the options, has helped them make better decisions and reduce anxiety.

Dr. Rabbie Hanna Henry Ford Health System

Your Digital Guide begins below: 2 Chapters / 2 Video Segments

Why PARP Inhibitors? (1)

1. After Recurrence: PARP Inhibitors Can Improve Ovarian Cancer Survival Rates

Dr. Rabbie Hanna

Data on the use of PARP inhibitors after an ovarian cancer recurrence "is very promising," says Dr. Hanna. "It has changed our survival rates."

Side-Effects (1)

2. Using “the Art of Medicine” to Help Mitigate PARP Inhibitors’ Side Effects

Dr. Rabbie Hanna

Oncologists explain how to lessen side effects of PARP inhibitors by adjusting the dose and encouraging lifestyle changes.